Apyx Medical Corp. (APYX)
3.78
-0.04
(-1.05%)
USD |
NASDAQ |
Feb 13, 14:18
Apyx Medical Cash from Investing (Quarterly) : -0.519M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Nephros, Inc. | 0.00 |
| Owlet, Inc. | -0.255M |
| Abbott Laboratories | -- |
| Plus Therapeutics, Inc. | 1.297M |
| Phibro Animal Health Corp. | -17.18M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.536M |
| Cash from Financing (Quarterly) | 0.045M |
| Free Cash Flow | -9.503M |
| Free Cash Flow Per Share (Quarterly) | -0.0995 |
| Free Cash Flow to Equity (Quarterly) | -4.189M |
| Free Cash Flow to Firm (Quarterly) | -2.583M |
| Free Cash Flow Yield | -6.27% |